Company Profile: At Verastem Oncology, we address urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. FDA approval of AVMAPKI…
Cookies?
A session cookie keeps you signed in. If you accept, we also use analytics cookies (Google Analytics and PostHog) to understand usage. Learn more
We couldn't check your fit for this role — add a CV to your profile to see it next time.